Status:
RECRUITING
A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Urothelial Carcinoma (UC)
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to select contents and tools for the future development of a web app aiming to support patients' navigation for empowering decision-making through a higher awar...
Eligibility Criteria
Inclusion
- histological diagnosis of urothelial carcinoma;
- ≥ 18 years old,
- candidate for systemic treatment with chemotherapy, immune-checkpoint inhibitors, antibody-drug conjugates, or target therapy (patients can be enrolled also if the treatment has started),
- possession of a mobile device (e.g., smartphone or personal computer) with the physical and psychological ability to use mobile devices,
- understanding and speaking the Italian language,
- ability to sign an informed consent.
Exclusion
- not possession of a mobile device,
- unwillingness to give informed consent.
Key Trial Info
Start Date :
June 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06982794
Start Date
June 30 2025
End Date
October 31 2025
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, Italy, 20132